Cita APA

Aichler, M., Motschmann, M., Jütting, U., Luber, B., Becker, K., Ott, K., . . . Walch, A. (2014). Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy. Impact Journals LLC.

Chicago Style Citation

Aichler, Michaela, et al. Epidermal Growth Factor Receptor (EGFR) Is an Independent Adverse Prognostic Factor in Esophageal Adenocarcinoma Patients Treated With Cisplatin-based Neoadjuvant Chemotherapy. Impact Journals LLC, 2014.

Cita MLA

Aichler, Michaela, et al. Epidermal Growth Factor Receptor (EGFR) Is an Independent Adverse Prognostic Factor in Esophageal Adenocarcinoma Patients Treated With Cisplatin-based Neoadjuvant Chemotherapy. Impact Journals LLC, 2014.